top of page
Neopharma – financial restructuring
RESTRUCTURING ADVISORY · HEALTHCARE · 2020
JRC advised the board and shareholders of Neopharma, a UAE pharmaceutical manufacturer with operations in Japan, on a financial restructuring of more than US$300 million.
KEY FACTS
Transaction type: RESTRUCTURING ADVISORY
Practice: Restructuring
Sector: Healthcare
Countries: United Arab Emirates, Japan
Deal size: $300m+
Status: Completed (2020)
JRC’S ROLE
Restructuring adviser to the board and shareholders
RELATED
bottom of page